Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference46 articles.
1. The promises and pitfalls of RNA-interference-based therapeutics;Castanotto;Nature,2009
2. RNA-based therapeutics: current progress and future prospects;Burnett;Chem Biol,2012
3. A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice;Creusot;Mol Ther,2010
4. Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion;Tcherepanova;BMC Mol Biol,2008
5. Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin;Karikó;Mol Ther,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma;Human Vaccines & Immunotherapeutics;2023-06-30
2. Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma;Clinical Cancer Research;2020-02-07
3. On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy;Frontiers in Oncology;2019-02-06
4. Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity;Journal of Controlled Release;2018-11
5. Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results;Journal for ImmunoTherapy of Cancer;2015-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3